SA
Sabir Ali Usman Ali Sayyed
About Sabir Ali Usman Ali Sayyed
Data last updated:
Sabir Ali Usman Ali Sayyed is a Director at Zeytin Pharma Private Limited (since 2018), Director at Incir Pharma Private Limited (since 2020) and Director at Medg Medicine Solutions Private Limited (since 2020). The companies operate in Business Services and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹1.42 Cr; the largest is Zeytin Pharma Private Limited at ₹1.39 Cr (FY 2025). Earlier, Sabir Ali Usman Ali Sayyed was a Director at Olear Healthcare Private Limited (from 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Sep 2018 | 2018 | ₹1.39 Cr (FY 2025) | Active | |
| Director | 27 Nov 2020 | 2020 | ₹3.2 Lakh (FY 2025) | Active | |
| Director | 26 Nov 2020 | 2020 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sabir Ali Usman Ali Sayyed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mosin Sattar Khatik | 07763048 | Zeytin Pharma Private Limited | Director |
| Shakiloddin Rahimoddin Kazi | 08976420 | Incir Pharma Private Limited | Director |
| Tanveer Ahmed Musa Shaikh | 08974766 | Incir Pharma Private Limited , Medg Medicine Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sabir Ali Usman Ali Sayyed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sabir Ali Usman Ali Sayyed
Sabir Ali Usman Ali Sayyed currently holds 3 directorships: Zeytin Pharma Private Limited (Director, since 21 Sep 2018, revenue ₹1.39 Cr (FY 2025)); Incir Pharma Private Limited (Director, since 27 Nov 2020, revenue ₹3.2 Lakh (FY 2025)); Medg Medicine Solutions Private Limited (Director, since 26 Nov 2020).
Sabir Ali Usman Ali Sayyed was first appointed on 16 Mar 2017 as Director at Olear Healthcare Private Limited. The most recent appointment on record is 27 Nov 2020 at Incir Pharma Private Limited.
The 2 current companies of Sabir Ali Usman Ali Sayyed that report revenue have a combined latest revenue of ₹1.42 Cr: Zeytin Pharma Private Limited ₹1.39 Cr (FY 2025); Incir Pharma Private Limited ₹3.2 Lakh (FY 2025).
Sabir Ali Usman Ali Sayyed held 1 earlier board appointment: Olear Healthcare Private Limited (Director, from 16 Mar 2017).
The current boards of Sabir Ali Usman Ali Sayyed's companies include Mosin Sattar Khatik (Zeytin Pharma Private Limited), Shakiloddin Rahimoddin Kazi (Incir Pharma Private Limited), Tanveer Ahmed Musa Shaikh (Incir Pharma Private Limited).